The onset of NIDDM and its relationship to clinical diagnosis in Egyptian adults

Diabetic Medicine

Volumn 13, Issue 4, 1996, Pages 337-340

  Thompson, T J ^a,d   Engelgau, M M ^a   Hegazy, M ^b   Ali, M A ^b   Sous, E S ^b   Badran, A ^b   Herman, W H ^c  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b MINISTRY OF HEALTH   (Egypt)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Diagnosis; Egypt; Epidemiology; Non insulin dependent diabetes mellitus; Retinopathy

Indexed keywords

ADULT; ARTICLE; DIABETIC RETINOPATHY; DISEASE DURATION; EGYPT; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PREVALENCE;

ADULT; AGE OF ONSET; AGED; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; EGYPT; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; REGRESSION ANALYSIS;

EID: 0030011990     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199604)13:4<337::AID-DIA71>3.0.CO;2-A     Document Type: Article

References (18)

1. King H, Rewers M. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diabetes Care 1993; 16; 157-177.
2. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 1992; 15: 815-819.
3. Ballard DJ, Humphrey LL, Melton LJ, Frohnert PP, Chu PC, O'Fallon WM, et al. Epidemiology of persistent proteinuria in type II diabetes mellitus. Population-based study in Rochester, Minnesota. Diabetes 1988; 37: 405-412.
4. Harris MI. Undiagnosed NIDDM: Clinical and public health issues. Diabetes Care 1993; 16: 642-652.
5. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med 1993; 329: 977-986.
6. Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. New Engl J Med 1993; 329: 304-309.
7. Herman WH, Ali MA, Aubert RE, Engelgau MM, Kenny SJ, Gunter EW, et al. Diabetes mellitus in Egypt - Risk factors and prevalence. Diabetic Med 1995; 12: 1126-1131.
8. WHO Expert Committee on Diabetes Mellitus. Diabetes Mellitus. Second Report. Technical Report Series 646. Geneva: WHO, 1980: 9-14.
9. Diabetic Retinopathy Study Research Group. VII. A modification of the Airlie House classification of diabetic retinopathy. Invest Ophthalmol Visual Sci 1981; 21: 210-226.
10. McCullagh P, Nelder JA. Generalized Linear Models, 2nd edn. New York: Chapman & Hall, 1989.
11. Aitkin M, Anderson D, Francis B, Hinde J. Statistical Modelling in GLIM. Oxford: Clarendon Press, 1989.
12. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. New York: Chapman & Hall, 1993.
13. Aptech Systems Inc. The GAUSS System Version 3.2.5. Maple Valley, WA: Aptech Systems Inc., 1994.
14. Jarrett Jr. Duration of non-insulin-dependent diabetes and development of retinopathy: analysis of possible risk factors. Diabetic Med 1986; 3: 261-263.
15. Aldington SJ, Kohmer EM, Nugent Z. Retinopathy at entry in the United Kingdom Prospective Diabetes Study (UKPDS) of maturity onset diabetes. Diabetic Med 1987; 4: 355.
16. Patrick AW, Leslie PJ, Clark BF, Frier BF. The natural history and associates of microalbuminuria in type 2 diabetes during the first year after diagnosis. Diabetic Med 1990; 7: 902-908.
17. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin epidemiologic study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthal 1994; 112: 1217-1228.
18. Centers for Disease Control and Prevention. Prevalence of selected risk factors for chronic disease by education level in racial/ethnic populations - U.S. Morbidity and Mortality Weekly Report 1994; 43: 894-899.